Filing Details

Accession Number:
0000899243-19-012641
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 16:28:02
Reporting Period:
2019-05-06
Accepted Time:
2019-05-08 16:28:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1403752 Zymeworks Inc. ZYME Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761966 Yuen Kai David Poon C/O Zymeworks Inc.
1385 West 8Th Avenue, Suite 540
Vancouver A1 V6H 3V9
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-06 800 $3.53 800 No 4 M Direct
Common Stock Disposition 2019-05-06 800 $19.20 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (Right to Buy) Disposition 2019-05-06 800 $0.00 800 $3.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,390 2012-01-01 2021-01-01 No 4 M Direct
Footnotes
  1. The exercise price of the stock option is CAD4.75. The U.S. dollar equivalent of the exercise price is $3.53 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432).
  2. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2011, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.